Affinity Asset Advisors, LLC
- SEC CIK
- 0001773195
- Latest filing
- Aug 13, 2026
VKTX holding history
Viking Therapeutics, Inc. in every 13F filed by Affinity Asset Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VKTX overviewAll 13F holders of VKTXFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −25,000−100.0% | Sold out | Holders |
| Q1 2025 | 25,000 | $603.8K | 0.1% | +25,000 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −50,000−100.0% | Sold out | Holders |
| Q1 2024 | 50,000 | $4.10M | 0.7% | −250,000−83.3% | Reduced | Holders |
| Q4 2023 | 300,000 | $5.58M | 1.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 300,000 | $3.32M | 1.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 300,000 | $4.86M | 1.9% | −322,249−51.8% | Reduced | Holders |
| Q1 2023 | 622,249 | $10.4M | 4.0% | +272,249+77.8% | Added | Holders |
| Q4 2022 | 350,000 | $3.29M | 1.5% | +100,000+40.0% | Added | Holders |
| Q3 2022 | 250,000 | $680.0K | 0.3% | +250,000 | New | Holders |